Celldex Therapeutics, Inc. · NASDAQ:CLDX

T. Rowe Price Associates Inc's stake in Celldex Therapeutics, Inc. fell to 3.60% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

T. Rowe Price Associates Inc's stake in Celldex Therapeutics, Inc. fell to 3.60%, 2,382,701 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
3.60%
Shares
2,382,701
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.3.60%2,382,701

Source

View original at SEC

Related